These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32713659)

  • 1. Novel compound heterozygous ACO2 mutations in an infant with progressive encephalopathy: A newly identified neurometabolic syndrome.
    Park JS; Kim MJ; Kim SY; Lim BC; Kim KJ; Seong MW; Lee JS; Chae JH
    Brain Dev; 2020 Oct; 42(9):680-685. PubMed ID: 32713659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometabolic syndrome.
    Sharkia R; Wierenga KJ; Kessel A; Azem A; Bertini E; Carrozzo R; Torraco A; Goffrini P; Ceccatelli Berti C; McCormick ME; Plecko B; Klein A; Abela L; Hengel H; Schöls L; Shalev S; Khayat M; Mahajnah M; Spiegel R
    J Inherit Metab Dis; 2019 Mar; 42(2):264-275. PubMed ID: 30689204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encephalopathy and cerebellar atrophy.
    Metodiev MD; Gerber S; Hubert L; Delahodde A; Chretien D; Gérard X; Amati-Bonneau P; Giacomotto MC; Boddaert N; Kaminska A; Desguerre I; Amiel J; Rio M; Kaplan J; Munnich A; Rötig A; Rozet JM; Besmond C
    J Med Genet; 2014 Dec; 51(12):834-8. PubMed ID: 25351951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive ACO2 variants as a cause of isolated ophthalmologic phenotypes.
    Gibson S; Azamian MS; Lalani SR; Yen KG; Sutton VR; Scott DA
    Am J Med Genet A; 2020 Aug; 182(8):1960-1966. PubMed ID: 32449285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2.
    Spiegel R; Pines O; Ta-Shma A; Burak E; Shaag A; Halvardson J; Edvardson S; Mahajna M; Zenvirt S; Saada A; Shalev S; Feuk L; Elpeleg O
    Am J Hum Genet; 2012 Mar; 90(3):518-23. PubMed ID: 22405087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel compound heterozygous mutations in ACO2 in a patient with progressive cerebral and cerebellar atrophy.
    Fukada M; Yamada K; Eda S; Inoue K; Ohba C; Matsumoto N; Saitsu H; Nakayama A
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00698. PubMed ID: 31106992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency due to a novel ACO2 deletion causes mitochondrial dysfunction in fibroblasts from a patient with dominant optic nerve atrophy.
    Neumann MA; Grossmann D; Schimpf-Linzenbold S; Dayan D; Stingl K; Ben-Menachem R; Pines O; Massart F; Delcambre S; Ghelfi J; Bohler J; Strom T; Kessel A; Azem A; Schöls L; Grünewald A; Wissinger B; Krüger R
    Sci Rep; 2020 Oct; 10(1):16736. PubMed ID: 33028849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant.
    Srivastava S; Gubbels CS; Dies K; Fulton A; Yu T; Sahin M
    J Child Neurol; 2017 Aug; 32(9):840-845. PubMed ID: 28545339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency.
    Sadat R; Barca E; Masand R; Donti TR; Naini A; De Vivo DC; DiMauro S; Hanchard NA; Graham BH
    Mol Genet Metab; 2016 May; 118(1):28-34. PubMed ID: 26992325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization on muscle tissue of a novel biallelic
    Ricci FS; Stanga S; Mezzanotte M; Marinaccio C; D'Alessandro R; Somà A; Sottemano S; Conio A; Morana G; Spada M; Boido M; Mongini TE
    JIMD Rep; 2024 Jan; 65(1):3-9. PubMed ID: 38186851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.
    Nasca A; Rizza T; Doimo M; Legati A; Ciolfi A; Diodato D; Calderan C; Carrara G; Lamantea E; Aiello C; Di Nottia M; Niceta M; Lamperti C; Ardissone A; Bianchi-Marzoli S; Iarossi G; Bertini E; Moroni I; Tartaglia M; Salviati L; Carrozzo R; Ghezzi D
    Orphanet J Rare Dis; 2017 May; 12(1):89. PubMed ID: 28494813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child Neurology: Progressive Cerebellar Atrophy and Retinal Dystrophy: Clues to an Ultrarare
    Lail N; Pandey AK; Venkatesh S; Noland RD; Swanson G; Pain D; Branson HM; Suzuki CK; Yoon G
    Neurology; 2023 Oct; 101(15):e1567-e1571. PubMed ID: 37460232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding the clinical and phenotypic heterogeneity associated with biallelic variants in ACO2.
    Blackburn PR; Schultz MJ; Lahner CA; Li D; Bhoj E; Fisher LJ; Renaud DL; Kenney A; Ibrahim N; Hashem M; Zain Seidahmed M; Hasadsri L; Schrier Vergano SA; Alkuraya FS; Lanpher BC
    Ann Clin Transl Neurol; 2020 Jun; 7(6):1013-1028. PubMed ID: 32519519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACO2 clinicobiological dataset with extensive phenotype ontology annotation.
    Guehlouz K; Foulonneau T; Amati-Bonneau P; Charif M; Colin E; Bris C; Desquiret-Dumas V; Milea D; Gohier P; Procaccio V; Bonneau D; den Dunnen JT; Lenaers G; Reynier P; Ferré M
    Sci Data; 2021 Aug; 8(1):205. PubMed ID: 34354088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Infantile Cerebellar-Retinal Degeneration With Compound Heterozygous Variants in
    Ha DJ; Park J; Seo GH; Lee K; Kwon YS; Lee JE; Kim SJ
    Front Genet; 2022; 13():729980. PubMed ID: 35368710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy.
    Reinson K; Õiglane-Shlik E; Talvik I; Vaher U; Õunapuu A; Ennok M; Teek R; Pajusalu S; Murumets Ü; Tomberg T; Puusepp S; Piirsoo A; Reimand T; Õunap K
    Am J Med Genet A; 2016 Aug; 170(8):2173-6. PubMed ID: 27250579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency.
    Abela L; Spiegel R; Crowther LM; Klein A; Steindl K; Papuc SM; Joset P; Zehavi Y; Rauch A; Plecko B; Simmons TL
    PLoS One; 2017; 12(5):e0176363. PubMed ID: 28463998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sibling study of isolated optic neuropathy associated with novel variants in the ACO2 gene.
    Kelman JC; Kamien BA; Murray NC; Goel H; Fraser CL; Grigg JR
    Ophthalmic Genet; 2018 Oct; 39(5):648-651. PubMed ID: 30118607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant
    Charif M; Gueguen N; Ferré M; Elkarhat Z; Khiati S; LeMao M; Chevrollier A; Desquiret-Dumas V; Goudenège D; Bris C; Kane S; Alban J; Chupin S; Wetterwald C; Caporali L; Tagliavini F; LaMorgia C; Carbonelli M; Jurkute N; Barakat A; Gohier P; Verny C; Barth M; Procaccio V; Bonneau D; Zanlonghi X; Meunier I; Weisschuh N; Schimpf-Linzenbold S; Tonagel F; Kellner U; Yu-Wai-Man P; Carelli V; Wissinger B; Amati-Bonneau P; Reynier P; ; Lenaers G
    Brain Commun; 2021; 3(2):fcab063. PubMed ID: 34056600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exome sequencing identifies novel missense and deletion variants in RTN4IP1 associated with optic atrophy, global developmental delay, epilepsy, ataxia, and choreoathetosis.
    D'Gama AM; England E; Madden JA; Shi J; Chao KR; Wojcik MH; Torres AR; Tan WH; Berry GT; Prabhu SP; Agrawal PB
    Am J Med Genet A; 2021 Jan; 185(1):203-207. PubMed ID: 33037779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.